Both in Pharmaceuticals
Madrigal Pharmaceuticals vs Spyre Therapeutics
Over the past year MDGL returned −9.9% and SYRE returned +331.0%; their daily moves had a correlation of 0.18.
MDGL −9.9% SYRE +331.0%Growth of $1, one year, split-adjusted
| Metric | MDGL | SYRE |
|---|---|---|
| Price | $400.43 | $99.04 |
| Market cap | $9.25B | $9.26B |
| Today | +1.04% | −0.23% |
| 1 month | −19.3% | +23.6% |
| 6 months | −25.8% | +35.7% |
| Year to date | −31.2% | +202.3% |
| 1 year | −2.9% | +316.5% |
| Revenue growth (YoY) | +50.1% | — |
| Gross margin | 100.0% | — |
| Net margin | 12.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 6.5× | — |
| Net cash | $619.7M | $1.07B |
| Dividend yield | — | — |
| Volatility (60d) | 34.1% | 59.0% |
| Short % of float | 14.7% | 15.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).